Research provides evidence that a drug used to slow the progression of the disease ALS shows promise in suppressing the self-renewing cancerous stem cells that challenge the present standards of care ...

A promising ALS drug may help combat glioblastoma by targeting the cancerous stem cells that fuel tumor growth.

In September 2023, doctors cut a hole in the side of Gary Woodland's skull. Thirteen months and one day later, Woodland is ...

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy.

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation ...

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy ...